NYSE - Delayed Quote USD

AbbVie Inc. (ABBV)

Compare
203.87 +2.37 (+1.18%)
At close: October 31 at 4:00 PM EDT
203.20 -0.67 (-0.33%)
Pre-Market: 5:07 AM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
55,000,000.00
54,318,000.00
58,054,000.00
56,197,000.00
45,804,000.00
Cost of Revenue
20,485,000.00
20,415,000.00
17,414,000.00
17,446,000.00
15,387,000.00
Gross Profit
34,515,000.00
33,903,000.00
40,640,000.00
38,751,000.00
30,417,000.00
Operating Expense
20,794,000.00
20,368,000.00
21,826,000.00
19,703,000.00
17,678,000.00
Operating Income
13,721,000.00
13,535,000.00
18,814,000.00
19,048,000.00
12,739,000.00
Net Non Operating Interest Income Expense
-1,735,000.00
-1,684,000.00
-2,044,000.00
-2,384,000.00
-2,280,000.00
Other Income Expense
-4,920,000.00
-5,601,000.00
-3,293,000.00
-3,675,000.00
-7,061,000.00
Pretax Income
7,066,000.00
6,250,000.00
13,477,000.00
12,989,000.00
3,398,000.00
Tax Provision
1,716,000.00
1,377,000.00
1,632,000.00
1,440,000.00
-1,224,000.00
Net Income Common Stockholders
5,298,000.00
4,820,000.00
11,782,000.00
11,468,000.00
4,556,000.00
Diluted NI Available to Com Stockholders
5,298,000.00
4,820,000.00
11,782,000.00
11,468,000.00
4,556,000.00
Basic EPS
3.00
2.75
6.69
6.53
2.62
Diluted EPS
2.99
2.72
6.63
6.45
2.62
Basic Average Shares
1,768,500.00
1,765,940.73
1,769,181.29
1,768,337.70
1,765,132.82
Diluted Average Shares
1,772,500.00
1,773,000.00
1,778,000.00
1,777,000.00
1,765,132.82
Total Operating Income as Reported
12,272,000.00
12,757,000.00
18,117,000.00
17,924,000.00
11,363,000.00
Total Expenses
41,279,000.00
40,783,000.00
39,240,000.00
37,149,000.00
33,065,000.00
Net Income from Continuing & Discontinued Operation
5,339,000.00
4,863,000.00
11,836,000.00
11,542,000.00
4,616,000.00
Normalized Income
6,495,920.46
5,583,720.00
12,578,755.00
12,586,575.00
5,672,310.00
Interest Income
770,000.00
540,000.00
186,000.00
39,000.00
174,000.00
Interest Expense
2,505,000.00
2,224,000.00
2,230,000.00
2,423,000.00
2,454,000.00
Net Interest Income
-1,735,000.00
-1,684,000.00
-2,044,000.00
-2,384,000.00
-2,280,000.00
EBIT
9,571,000.00
8,474,000.00
15,707,000.00
15,412,000.00
5,852,000.00
EBITDA
18,087,000.00
17,172,000.00
24,174,000.00
23,933,000.00
12,323,000.00
Reconciled Cost of Revenue
20,485,000.00
20,415,000.00
17,414,000.00
17,446,000.00
15,387,000.00
Reconciled Depreciation
8,516,000.00
8,698,000.00
8,467,000.00
8,521,000.00
6,471,000.00
Net Income from Continuing Operation Net Minority Interest
5,339,000.00
4,863,000.00
11,836,000.00
11,542,000.00
4,616,000.00
Total Unusual Items Excluding Goodwill
-1,528,000.00
-924,000.00
-845,000.00
-1,175,000.00
-1,447,000.00
Total Unusual Items
-1,528,000.00
-924,000.00
-845,000.00
-1,175,000.00
-1,447,000.00
Normalized EBITDA
19,615,000.00
18,096,000.00
25,019,000.00
25,108,000.00
13,770,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-371,079.54
-203,280.00
-102,245.00
-130,425.00
-390,690.00
12/31/2020 - 1/2/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers